Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 7/20 | 0.39 |
| ▸ | NPY1R | P25929 | 5/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.39 |
| ▸ | OTC | P00480 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.36 |
| ▸ | NPY2R | P49146 | 4/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.36 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | RRM1 | P23921 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28712062 | 1.00 | NPY4R (0.39) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL288133 | 1.00 | NPY4R (0.39) | NPY4RNPY1RDPP7OTCALOX15 | |
| Hydrochloric Acid SCHEMBL8039440 | 0.98 | NPY4R (0.38) | NPY4RNPY1RDPP7OTCALOX15 | |
| Hydrochloric Acid SCHEMBL8040222 | 0.98 | NPY4R (0.38) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL27722340 | 0.95 | NPY4R (0.37) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL16194087 | 0.95 | NPY4R (0.38) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL7061485 | 0.95 | NPY4R (0.38) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL3891500 | 0.94 | NPY4R (0.36) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL1840068 | 0.94 | NPY4R (0.36) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL769420 | 0.94 | GNAI3 (0.40) | NPY4RNPY1RDPP7OTCALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240269228-A1 | SELECTIVE PENICILLAMINE SUBSTITUTION ENABLES DEVELOPMENT OF A POTENT ANALGESIC PEPTIDE THAT ACTS THROUGH A NON-OPIOID BASED MECHANISM | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2024-08-15 | — | — | US | disclosed |
| EP-4346868-A1 | SELECTIVE PENICILLAMINE SUBSTITUTION ENABLES DEVELOPMENT OF A POTENT ANALGESIC PEPTIDE THAT ACTS THROUGH A NON-OPIOID BASED MECHANISM | University of Utah Research Foundation (US) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022256066-A1 | SELECTIVE PENICILLAMINE SUBSTITUTION ENABLES DEVELOPMENT OF A POTENT ANALGESIC PEPTIDE THAT ACTS THROUGH A NON-OPIOID BASED MECHANISM | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2022-12-08 | — | — | WO | disclosed |
| US-20210130806-A1 | ENGINEERED BACTERIA EXPRESSING RACEMASE FOR TREATING DISEASES ASSOCIATED WITH HYPERAMMONEMIA | SYNLOGIC OPERATING COMPANY, INC. | 2021-05-06 | — | — | US | disclosed |
| CN-1809590-A | Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia | AVANIR PHARMACEUTICALS (US) | 2006-07-26 | — | — | CN | disclosed |
| US-5385940-A | Treatment of stroke with nitric-oxide releasing compounds | THE GENERAL HOSPITAL CORPORATION (US) | 1995-01-31 | — | — | US | disclosed |